Powdered Bacopa Extract (500 mg)
|
|
Powdered Echinacea Pallida Extract (1 g)
|
|
Powdered Echinacea Purpurea Extract (1 g)
|
|
Powdered Eleuthero Extract (1.5 g)
|
|
Powdered Forskohlii Extract (500 mg)
|
|
Powdered Garcinia Hydroxycitrate Extract (500 mg)
|
|
Powdered Ginger (500 mg)
|
|
Powdered Centella Asiatica Extract (1 g)
|
|
Propantheline Bromide Related Compound A (50 mg) (9-Hydroxypropantheline bromide)
|
|
Powdered Kava Extract (1 g)
|
|
Polyallylamine Hydrochloride (200 mg) (2-Propen-1-amine, hydrochloride (1:1), homopolymer)
|
|
Polyamide 6 (1 g)
|
|
Polyoxyl 23 Lauryl Ether (0.5 g)
|
|
Polyoxyl Oleate (500 mg)
|
|
Polyoxyl 10 Stearyl Ether (1 g)
|
|
Powdered Malabar-Nut-Tree, Leaf Extract (1 g)
|
|
Partially-Neutralized Methacrylic Acid and Ethyl Acrylate Copolymer (1:1) (1 g)
|
|
Powdered Milk Thistle Extract (250 mg)
|
|
PS NMR System Suitability (1 mg)
|
|
Paclitaxel (200 mg)
|
|
Paclitaxel Related Compound A (20 mg) (Cephalomannine)
|
|
Paclitaxel Related Compound B (20 mg) (10-deacetyl-7-epipaclitaxel)
|
|
Paclitaxel Impurity Mixture (10 mg) (This mixture contains paclitaxel and paclitaxel benzyl analog)
|
|
Padimate O (300 mg)
|
|
Paliperidone Resolution Mixture (20 mg)
|
|
Paliperidone (200 mg)
|
|
Paliperidone Related Compound A (20 mg) (3-Ethyl-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-alpha]pyrimidin-4-one)
|
|
Paliperidone Related Compound B (20 mg) (6-fluoro-3-(piperidin-4-yl)benzoisoxazole hydrochloride)
|
|
Paliperidone Related Compound C (20 mg) (3-(2-Chloroethyl)-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one)
|
|
Paliperidone Related Compound D (20 mg) (4-(6-Fluorobenzo[d]isoxazol-3-yl)-1-[2-(9-hydroxy-2-methyl-4-oxo-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-3-yl)ethyl]piperidine 1-oxide)
|
|
Palmitic Acid (500 mg)
|
|
Palm Oil (1 g)
|
|
Palonosetron Hydrochloride (100 mg)
|
|
Palonosetron Enantiomer (15 mg) ((3aR)-2-[(3R)-Quinuclidin-3-yl]-2,3,3a,4,5,6-hexahydro-1H-benzo[de]isoquinolin-1-one hydrochloride)
|
|
Palonosetron Related Compound A (15 mg) ((3aS)-1-Oxo-2-[(3S)-quinuclidin-3-yl]-2,3,3a,4,5,6-hexahydro-1H-benzo[de]isoquinoline 1-oxide)
|
|
Palonosetron Related Compound B (15 mg) ((3S)-3-(1-Oxo-5,6-dihydro-1H-benzo[de]isoquinolin-2(4H)-yl)quinuclidine 1-oxide)
|
|
Palonosetron Related Compound C (15 mg) ((S)-2-[(3R)-Quinuclidin-3-yl]-2,3,3a,4,5,6-hexahydro-1H-benzo[de]isoquinolin-1-one hydrochloride)
|
|
Palonosetron Related Compound D (15 mg) ((R)-2-[(3S)-Quinuclidin-3-yl]-2,3,3a,4,5,6-hexahydro-1H-benzo[de]isoquinolin-1-one hydrochloride)
|
|
Palonosetron Related Compound E (15 mg) (2-[(3S)-Quinuclidin-3-yl]-2,4,5,6-tetrahydro-1H-benzo[de]isoquinolin-1-one hydrochloride)
|
|
Pamabrom Related Compound A (30 mg) (8-Chlorotheophylline)
販売終了
|
|
Pamidronate Disodium (100 mg)
|
|
Pamoic Acid (250 mg)
|
|
Pancreatin Amylase and Protease (2 g) (COLD SHIPMENT REQUIRED)
|
|
Pancreatin Lipase (2 g) (COLD SHIPMENT REQUIRED)
|
|
Pancuronium Bromide (500 mg)
|
|
Pancuronium Bromide Related Compound A (15 mg) (1,1'-(3alpha,17beta-dihydroxy-5alpha-androstan-2beta,16beta-ylene) bis(1-methylpiperidinium) dibromide)
|
|
Pancuronium Bromide Related Compound B (15 mg) (1,1'-(17beta-Acetoxy-3alpha-hydroxy-5alpha-androstan-2beta,16beta-ylene) bis(1-methylpiperidinium) dibromide)
|
|
Pancuronium Bromide Related Compound C (15 mg) (1,1'-(3alpha-acetoxy-17beta-hydroxy-5alpha-androstan-2beta,16beta-ylene) bis(1-methylpiperidinium) dibromide)
|
|
Racemic Panthenol (200 mg)
|
|
Pantolactone (500 mg)
|
|
Pantoprazole Sodium (250 mg)
|
|
Pantoprazole Related Compound A (25 mg) (5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]sulfonyl]-1H-benzimidazole)
|
|
Pantoprazole Related Compound B (25 mg) (5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]thio]-1H-benzimidazole)
|
|
Pantoprazole Related Compound C (20 mg) (5-(difluoromethoxy)-1H-benzimidazole-2-thiol)
|
|
Pantoprazole Related Compounds D and F Mixture (20 mg)
|
|
Pantoprazole Related Compound E (20 mg) (6,6'-Bis(difluoromethoxy)-2,2'-bis[(3,4-dimethoxypyridin-2-yl)methylsulfinyl]-1H,1'H-5,5'-bibenzimidazole)
|
|
Papain (1 g) (COLD SHIPMENT REQUIRED)
|
|
Papaverine Hydrochloride (200 mg)
|
|
Parachlorophenol (500 mg)
|
|
Paraffin (1 g)
|
|
パルベンダゾール
|
|
Paricalcitol (10 mg) (COLD SHIPMENT REQUIRED)
|
|
Paricalcitol Solution (3 mL) (COLD SHIPMENT REQUIRED)
|
|
Paromomycin Sulfate (125 mg)
|
|
Paroxetine Hydrochloride (350 mg)
|
|
Paroxetine Related Compound B (15 mg) ((3S,4R)-3-[(Benzodioxol-5-yloxy)methyl]-4-phenylpiperidine hydrochloride)
|
|
Paroxetine Related Compound C (30 mg) ((3R,4S)-3-[(Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine hydrochloride) OR ((+)-trans-Paroxetine hydrochloride)
|
|
Paroxetine Related Compound D (10 mg) ((3RS,4RS)-3-[(Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine hydrochloride); cis-paroxetine hydrochloride
|
|
Paroxetine Related Compound E Mixture (1-Methyl-4-(p-fluorophenyl)-1,2,3,6-tetrahydropyridine in Paroxetine Hydrochloride Matrix)
販売終了
|
|
Paroxetine Related Compound F (25 mg) ((3S,4R)-3-[(Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-1-methylpiperidine)
|
|
Paroxetine Related Compound G (10 mg) ((+/-)trans-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4''-fluorophenyl-4'-phenyl)piperidine hydrochloride)
|
|
Paroxetine System Suitability Mixture A (50 mg)
|
|
Parthenolide (25 mg)
|
|
Particle Count Set (2 blanks (28 mL each) and 2 suspensions (25 mL each))
|
|
Peanut Oil (1 g)
|
|
Pemetrexed Disodium (100 mg) (Disodium N-{p-[2-(2-amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl}-l-glutamate heptahydrate)
|
|
ペンブトロール硫酸塩
販売終了
|
|
Penicillamine (200 mg)
|
|
Penicillamine Disulfide (200 mg) (3,3'-Dithiodi-D-valine)
|
|
Penicillin G Benzathine (200 mg)
|
|
ペニシリンGカリウム
|
|
Penicillin G Procaine (200 mg)
|
|
Penicillin G Sodium (150 mg)
|
|
ペニシリンV
|
|
Penicillin V Potassium (200 mg)
|
|
Pentamidine Isethionate (200 mg)
|
|
Pentane (1.2 mL/ampule; 3 ampules)
|
|
1-Pentanol (1.2 mL/ampule; 3 ampules)
|
|
Pentetic Acid (100 mg)
|
|
Pentoxifylline (200 mg)
|
|
Powdered Black Pepper Extract (1 g)
|
|
Pepsin for Assay (5 x 1 g) (COLD SHIPMENT REQUIRED)
|
|
Perflubron (0.5 mL)
|
|
Pergolide Mesylate (200 mg)
|
|
Pergolide Sulfoxide (50 mg) ((8Beta)-8-[(Methylsulfinyl)methyl]-6-propyl-D-ergoline)
|
|
Perindopril Erbumine (100 mg)
|
|
Perindopril Related Compound A (20 mg) ((2S,3aS,7aS)-octahydro-1H-indole-2-carboxylic acid)
|
|
Perindopril Related Compound B (10 mg) ((2S,3aS,7aS)-1-{(S)-2-[(S)-1-carboxybutylamino]propanoyl}octahydro-1H-indole-2-carboxylic acid monohydrate)
|
|
Perindopril Related Compound C (20 mg) ((S)-2-[(3S,5aS,9aS,10aS)-3-methyl-1,4-dioxodecahydropyrazino[1,2-a]indol-2(1H)-yl]pentanoic acid)
|
|
Perindopril Related Compound D (25 mg) ((S)-2-{(3S,5aS,9aS,10aR)-3-methyl-1,4-dioxodecahydropyrazino[1,2-a]indol-2(1H)-yl}pentanoic acid)
|
|
Perindopril Related Compound E (10 mg) ((2S,3aS,7aS)-1-{(S)-2-[(S)-1-Isopropoxy-1-oxopentan-2-ylamino]propanoyl}octahydro-1H-indole-2-carboxylic acid, tert-butylamine)
|
|
Perindopril Related Compound F (10 mg) ((S)-ethyl 2-{(3S,5aS,9aS,10aS)-3-methyl-1,4-dioxodecahydropyrazino[1,2-a]indol-2(1H)-yl}pentanoate)
|
|
Perindopril Related Compound K (10 mg) ((3S,5aS,9aS,10aS)-3-methyldecahydropyrazino[1,2-a]indole-1,4-dione)
|
|
Perphenazine (200 mg)
|
|
Perphenazine Related Compound B (15 mg) (2-{4-[3-(10H-phenothiazin-10-yl)propyl]piperazin-1-yl}ethanol)
|
|
Perphenazine Sulfoxide (25 mg)
|
|
Phenacetin (500 mg)
|
|
Phenacetin Melting Point Standard (1 g) (Approximately 135 degrees)
|
|
Phenazopyridine Hydrochloride (200 mg)
|
|
Phenelzine Sulfate (200 mg)
|
|
Pheniramine Maleate (150 mg)
|
|
Phenol (500 mg)
|
|
フェノチアジン
販売終了
|
|
Phenoxybenzamine Hydrochloride (250 mg)
|
|
Phenoxyethanol (500 mg) (2-Phenoxyethanol)
|
|
フェンスクシミド
販売終了
|
|
Phentolamine Mesylate (200 mg)
|
|
L-Phenylalanine (200 mg)
|
|
Phenylbutazone (250 mg)
|
|
Phenylephrine Bitartrate (25 mg)
|
|
Phenylephrine Hydrochloride (200 mg)
|
|
Phenylephrine Related Compound C (30 mg) (1-(3-Hydroxyphenyl)-2-(methylamino)ethan-1-one hydrochloride)
|
|
Phenylephrine Related Compound D (30 mg) ((R)-3-{2-[Benzyl(methyl)amino]-1-hydroxyethyl}phenol)
|
|
Phenylephrine Related Compound E (30 mg) (2-[Benzyl(methyl)amino]-1-(3-hydroxyphenyl)ethan-1-one hydrochloride)
|
|
Phenylethyl Alcohol (1 mL)
|
|
Phenylephrine Related Compound F (30 mg) ((R)-2-Methyl-1,2,3,4-tetrahydroisoquinoline-4,8-diol hydrochloride monohydrate)
|
|
Phenylephrine Related Compound G (30 mg) ((R)-N-(2-Hydroxy-2-(3-hydroxyphenyl)ethyl)-N-methylglycine)
|
|
5-Phenylhydantoin (100 mg)
|
|
Phenyl Salicylate Melting Point Standard (1 g) (COLD SHIPMENT REQUIRED) (Approximately 41 degrees)
|
|
Phenyltoloxamine Citrate (100 mg)
|
|
Phenyltoloxamine Related Compound A (50 mg) (2-(2-benzylphenoxy)ethylmethylamine hydrochloride)
|
|
Phenytoin (200 mg)
|
|
Phenytoin Related Compound A (50 mg) (2,2-Diphenylglycine)
|
|
Phenytoin Related Compound B (50 mg) (2,2-Diphenyl-2-ureidoacetic acid)
|
|
Phenytoin Sodium (200 mg)
|
|
Phosphated Riboflavin (100 mg)
|
|
Phosphoric Acid (1.5 mL/ampule; 3 ampules)
|
|
Phthalic Acid (50 mg)
|
|
Phthalazine (20 mg)
|
|
Phyllanthin (15 mg)
|
|
Powdered Phyllanthus Amarus Extract (1 g)
|
|
Physostigmine Salicylate (200 mg)
|
|
Phytonadione (100 mg x 5 ampules) (Vitamin K1)
|
|
Pilocarpine (300 mg)
|
|
Pilocarpine Hydrochloride (200 mg)
|
|
Pilocarpine Nitrate (200 mg)
|
|
Pimozide (200 mg)
|
|
Pindolol (200 mg)
|
|
Pioglitazone Hydrochloride (100 mg)
|
|
Piperacillin (350 mg)
|
|
Piperacillin Related Compound E (25 mg) (1-ethylpiperazine-2,3-dione)
|
|
Piperazine (200 mg)
|
|
Piperazine Adipate (200 mg)
|
|
Piperazine Citrate (200 mg)
|
|
Piperazine Dihydrochloride (200 mg)
|
|
Piperazine Phosphate (200 mg)
|
|
Piperine (20 mg)
|
|
酢酸ピルブテロール (AS)
販売終了
|
|
Piroctone Olamine (200 mg)
|
|
Piroctone Related Compound A (15 mg) ((2-[5-methyl-3-(2,4,4-trimethylpentyl)-4,5-dihydroisoxazol-5-yl]acetic acid) 2-aminoethanol salt)
|
|
Piroctone Related Compound B (25 mg) (4-methyl-6-(2,4,4-trimethylpentyl)-2H-pyran-2-one)
|
|
Piroxicam (125 mg)
|
|
Plant Stanol Esters (10 x 100 mg)
|
|
Plastic Additive 1 (100 mg) (Ethylene bis[3,3-bis[3-(1,1-dimethylethyl)-4-hydroxyphenyl] butanoate])
|
|
Plastic Additive 2 (200 mg) (pentaerythrityl tetrakis[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate])
|
|
Plastic Additive 3 (200 mg) (2,2',2'',6,6',6''-hexa-tert-butyl-4,4',4''-[(2,4,6-trimethyl-1,3,5-benzenetriyl)trismethylene]triphenol)
|
|
Plastic Additive 4 (200 mg) (Octadecyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate)
|
|
Plastic Additive 5 (200 mg) (Tris(2,4-di-tert-butylphenyl) phosphite)
|
|
Plastic Additive 6 (200 mg) (1,3,5-Tris(3,5-di-tert-butyl-4-hydroxybenzyl)-s-triazine-2,4,6(1H,3H,5H)-trione)
|
|
Plastic Additive 8 (100 mg) (Dioctadecyl disulfide)
|
|
Plastic Additive 9 (100 mg) (Didodecyl 3,3'-thiodipropionate)
|
|
Plastic Additive 10 (100 mg) (dioctadecyl 3,3'-thiodipropionate)
|
|
Plastic Additive 11 (100 mg) (Copolymer of Dimethyl Succinate and (4-hydroxy-2,2,6,6-tetramethylpiperidin-1-yl)ethanol))
|
|
Plastic Additive 12 (100 mg) (Oleamide)
|
|
Plastic Additive 13 (100 mg) (Erucamide)
|
|
Plastic Additive 14 (100 mg) (Di(2-ethylhexyl) phthalate)
|
|
Plastic Additive 15 (100 mg) (Epoxidized Soya Oil)
|
|
Plastic Additive 18 (5 x 25 mg)
|
|
Polacrilex Resin (100 mg) (Methacrylic acid polymer with divinylbenzene)
|
|
Polacrilin Potassium (200 mg)
|
|
Poloxalene (500 mg)
|
|
Poloxamer Liquid (1 mL)
|
|
Poloxamer Solid (1 g)
|
|
Polydatin (20 mg) (3-Hydroxy-5-[(E)-2-(4-hydroxyphenyl)vinyl]phenyl Beta-D-glucopyranoside)
販売終了
|
|
Polydextrose (200 mg)
|
|
Polydimethylsiloxane (500 mg)
|
|
Polyethylene Glycol 200 (1 g)
|
|
Polyethylene Glycol 300 (1 g)
|
|
Polyethylene Glycol 400 (1 g)
|
|
Polyethylene Glycol 600 (1 g)
|
|
Polyethylene Glycol 1000 (1 g)
|
|
Polyethylene Glycol 3000 (1 g)
|
|
Polyethylene Glycol 3350 (1 g)
|
|
Polyethylene Glycol 4000 (1 g)
|
|
Polyethylene Glycol 6000 (1 g)
|
|
Polyethylene Glycol 8000 (1 g)
|
|
Polyethylene Oxide (100 mg)
|
|
Polyglyceryl 3 Diisostearate (1 mL)
|
|
Polyglyceryl 6 Dioleate (1 g)
|
|
Polyisobutylene (1 g)
|
|
Polymyxin B Sulfate (200 mg) (COLD SHIPMENT REQUIRED)
|
|
Polygonum multiflorum Root Dry Extract (200 mg)
|
|
Polyoxyl 35 Castor Oil (1 g)
|
|
Polyoxyl 15 Hydroxystearate (500 mg)
|
|
Polyoxyl 10 Oleyl Ether (1 mL)
|
|
Polyoxyl 2 Stearyl Ether (1 g)
|
|
Polyoxyl 20 Stearyl Ether (1 g)
|
|
Polyoxyl 6 Stearate (200 mg)
|
|
Polyoxyl 8 Stearate (200 mg)
|
|
Polyoxyl 32 Stearate (200 mg)
|
|
Polyoxyl 75 Stearate (200 mg)
|
|
Polyoxyl 100 Stearate (200 mg)
|
|
Polyoxyl 20 Cetostearyl Ether (100 mg)
|
|
Polyoxyl 40 Stearate (200 mg)
|
|
Polysorbate 20 (2 g)
|
|
Polysorbate 40 (2 g)
|
|
Polysorbate 60 (2 g)
|
|
Polysorbate 80 (4 x 0.5 g)
|
|
Poly(ethylene-vinyl acetate) (1 g)
|
|
Polyvinyl Acetate (1 g)
|
|
Polyvinyl Acetate Dispersion (1 g)
|
|
Polyvinyl Alcohol (100 mg)
|
|
Polyvinyl Chloride (100 mg)
|
|
Potassium Benzoate (1 g)
|
|
Potassium Bicarbonate (1 g)
|
|
Potassium Chloride (1 g)
|
|
Potassium Citrate (1 g)
|
|
Potassium Iodide (1 g)
|
|
Potassium Nitrate (100 mg)
|
|
Potassium Nitrate Melting Point Standard (1 g) (Potassium Nitrate)
|
|
Potassium Sorbate (1 g)
|
|
Potassium Acetate (500 mg) (AS)
|
|
Potassium Bitartrate (3 g)
|
|
Potassium Gluconate (200 mg)
|
|
Potassium Guaiacolsulfonate (500 mg)
|
|
Potassium Sucrose Octasulfate (300 mg)
|
|
Potassium Trichloroammineplatinate (25 mg)
|
|
Povidone (100 mg)
|
|
Pralidoxime Chloride (200 mg)
|
|
Pramipexole Related Compound A (15 mg) ((S)-4,5,6,7-Tetrahydrobenzothiazole-2,6-diamine)
|
|
Pramipexole Related Compound D (25 mg) ((R)-2-Amino-4,5,6,7-tetrahydro-6-(propylamino)benzothiazole dihydrochloride)
|
|
Pramipexole Related Compound G (25 mg) ((6S,7S)-2-Amino-6-(propylamino)-4,5,6,7-tetrahydrobenzothiazol-7-ol)
|
|
Pramipexole Dihydrochloride Monohydrate (200 mg)
|
|
Pramoxine Hydrochloride (400 mg)
|
|
Prasugrel Hydrochloride (150 mg) (5-[2-Cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate hydrochloride)
|
|
Pravastatin 1,1,3,3-Tetramethylbutylamine (200 mg)
|
|
Pravastatin Sodium (50 mg)
|
|
Pravastatin Related Compound A (10 mg) (Sodium (3R,5R)-3,5-dihydroxy-7-[(1S,2R,3S,8S,8aR)-3-hydroxy-2-methyl-8-[[(2S)-2-methylbutanoyl]oxy]-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] heptanoate)
|
|
Pravastatin Related Compound B (20 mg) (sodium (3R,5R)-3,5-dihydroxy-7-((1S,2S,6R,8S,8aR)-6-hydroxy-2-methyl-8-((S)-2-methylbutanoyloxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)heptanoate)
|
|
Praziquantel (200 mg)
|
|
Praziquantel Related Compound A (20 mg) (2-benzoyl-1,2,3,6,7,11b-hexahydro-4H-pyrazino [2,1-a]isoquinolin-4-one)
|
|
Praziquantel Related Compound B (50 mg) (2-(cyclohexylcarbonyl)-2,3,6,7-tetrahydro-4H-pyrazino [2,1-a]isoquinolin-4-one)
|
|
Praziquantel Related Compound C (50 mg) (2-(N-formylhexahydrohippuroyl)-1,2,3,4-tetrahydroisoquinolin-1-one)
|
|
Prazosin Hydrochloride (350 mg)
|
|
Prazosin Related Compound D (25 mg) (Furan-2-yl(piperazin-1-yl)methanone)
|
|
Prednicarbate (200 mg)
|
|
Prednicarbate Related Compound A (20 mg) (1,2-Dihydroprednicarbate)
|
|
Prednicarbate Related Compound B (20 mg) (Prednisolone-17-ethylcarbonate)
|
|
Prednicarbate Related Compound C (20 mg) (prednisolone-21-propionate)
|
|
Prednisolone (200 mg)
|
|
Prednisolone Hemisuccinate (125 mg)
|
|
Prednisolone Sodium Phosphate (500 mg)
|
|
Prednisolone Tebutate (200 mg)
|
|
プレドニゾン
|
|
Pregabalin Related Compound C (25 mg) (COLD SHIPMENT REQUIRED) (4-Isobutylpyrrolidin-2-one)
|
|
Prilocaine (200 mg) (COLD SHIPMENT REQUIRED)
|
|
Prilocaine Hydrochloride (200 mg)
|
|
Prilocaine Related Compound A (100 mg) (o-Toluidine hydrochloride)
|
|
Prilocaine Related Compound B (50 mg) ((RS)-N-(4-methylphenyl)-2-(propylamino)propanamide)
|
|
Primaquine Phosphate (200 mg)
|
|
Primaquine Related Compound A (15 mg) (8-[(4-Aminopentyl)amino]-6-methoxyquinoline)
|
|
Primidone (200 mg)
|
|
Primidone Related Compound A (20 mg) (2-Ethyl-2-phenylmalonamide)
|
|
Primidone Related Compound C (20 mg) (2-phenyl butyramide)
|
|
Probenecid (200 mg)
|
|
Probucol (200 mg)
|
|
Probucol Related Compound A (25 mg) (2,2',6,6'-tetra-tert-butyldiphenoquinone)
|
|
Probucol Related Compound C (4-[(3,5-ジ-tert-ブチル-2-ヒドロキシフェニルチオ)イソプロピリデンチオ]-2,6-ジ-tert-ブチルフェノール)
販売終了
|
|
Procainamide Hydrochloride (200 mg)
|
|
Procaine Hydrochloride (200 mg)
|
|
Procarbazine Hydrochloride (200 mg)
|
|
Prochlorperazine Maleate (200 mg)
|
|
Prochlorperazine Related Compound A (10 mg) (4-Chloro-10-[3-(4-methylpiperazin-1-yl)propyl]-10H-phenothiazine dihydrochloride)
|
|
Procyclidine Hydrochloride (200 mg)
|
|
Progesterone System Suitability Mixture (40 mg) (Mixture contains 20-alpha-Progerol, 20-Beta-Progerol, 17alpha-Progesterone, 20-alpha-Progerol acetate, 20-Beta-Progerol acetate and Cyclohexylidene progesterone in Progesterone)
|
|
Progesterone (200 mg)
|
|
Progesterone Related Compound H (25 mg) (Pregna-4,6-diene-3,20-dione)
|
|
Proguanil Related Compound A (25 mg) (1-cyano-3-isopropylguanidine)
|
|
Proguanil Hydrochloride (200 mg)
|
|
Proguanil Related Compound C (25 mg) (1,5-bis(4-chlorophenyl)biguanide hydrochloride)
|
|
Proguanil Related Compound D (25 mg) (1,5-bis(1-methylethyl)biguanide hydrochloride)
|
|
Proguanil Related Compound E (25 mg) (1-(4-chlorophenyl)-3-cyanoguanidine)
|
|
Proguanil Related Compound F (25 mg) (1-(3,4-dichlorophenyl)-5-isopropylbiguanide hydrochloride)
|
|
Proguanil Related Compound G (25 mg) (1-(3-chlorophenyl)-5-isopropylbiguanide hydrochloride)
|
|
L-Proline (200 mg)
|
|
Promazine Hydrochloride (200 mg)
|
|
Pimobendan (100 mg)
|
|
Pimobendan Related Compound A (15 mg) (4-[2-(4-Methoxyphenyl)-1H-benzimidazol-5-yl]-3-methyl-4-oxobutanoic acid)
|
|
Pimobendan Related Compound B (15 mg) (N-[2-Amino-4-(4-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)phenyl]-4-methoxybenzamide)
|
|
Promethazine Hydrochloride (500 mg)
|
|
Promethazine Related Compound B (25 mg) (N,N-Dimethyl-2-(10H-phenothiazin-10-yl)propan-1-amine hydrochloride)
|
|
プロパフェノン塩酸塩
|
|
Propafenone Related Compound A (20 mg) (N-{2-Hydroxy-3-[2-(3-phenylpropanoyl)phenoxy]propyl}-N-propylformamide)
|
|
Propafenone Related Compound B (50 mg) (RS,E)-1-[2-[2-Hydroxy-3-(propylamino)propoxy]phenyl]-3-phenylprop-2-en-1-one)
|
|
1-Propanol (1.2 mL/ampule; 3 ampules)
|
|
2-Propanol (1.2 mL/ampule; 3 ampules)
販売終了
|
|
2-Propanol System Suitability (3 x 1 mL)
販売終了
|
|
Propanolamine (100 mg) (3-aminopropan-1-ol)
|
|
1,3-Propanediol (1 mL)
|
|
Propantheline Bromide (200 mg)
|
|
Proparacaine Hydrochloride (200 mg)
|
|
Propionic Acid (1.5 mL/ampule; 3 ampules)
|
|
Propofol (500 mg)
|
|
Propofol Resolution Mixture (100 mg) (Propofol, 2,6-diisopropylphenyl isopropylether, and 2-isopropyl-6-n-propylphenol)
|
|
Propofol Related Compound A (25 mg) (3,3',5,5'-Tetraisopropylbiphenyl-4,4'-diol)
|
|
Propofol Related Compound B (30 mg) (2,6-Diisopropyl-1,4-benzoquinone)
|
|
Propofol Related Compound C (25 mg) (2,6-diisopropylphenyl isopropyl ether)
|
|
Propranolol Hydrochloride (200 mg)
|
|
Propyl Acetate (1.2 mL/ampule; 3 ampules)
|
|
Propylene Carbonate (200 mg)
|
|
Propylene Glycol Mono And Dicaprylate (1 g)
|
|
Propylene Glycol Monocaprylate (1 g) (Propylene Glycol Monocaprylate Type II)
|
|
Propylene Glycol Dicaprylate/Dicaprate (1 mL)
|
|
Propylene Glycol (5 x 1 mL)
|
|
Propylene Glycol Dilaurate (500 mg)
|
|
Propylene Glycol Monolaurate Type I (500 mg)
|
|
Propylene Glycol Monolaurate Type II (500 mg)
|
|
Propyl Gallate (200 mg)
|
|
Propylene Oxide (5 x 0.1 mL)
|
|
Propylparaben (200 mg)
|
|
Propylthiouracil (200 mg)
|
|
Prostaglandin A1 (25 mg)
|
|
Prostaglandin B1 (25 mg) ((13E,15S)-15-Hydroxy-9-oxoprosta-8(12),13-dien-1-oic acid)
|
|
Protamine Sulfate (2.69 mg)
|
|
Protriptyline Hydrochloride (200 mg)
|
|
Pseudoisoeugenyl 2-Methylbutyrate (4 x 50 mg) ((E)-4-Methoxy-2-(prop-1-en-1-yl)phenyl 2-methylbutanoate)
|
|
Pyrantel Pamoate (500 mg)
|
|
Pyrantel Related Compound A (25 mg) ((Z)-1-Methyl-2-[2-(2-thiophenyl)vinyl]-1,4,5,6-Tetrahydropyrimidine 4,4'-methylenebis[3-hydroxy-2-naphthoate] (1:1))
|
|
Pyrantel Tartrate (200 mg)
|
|
Pyrazinamide (200 mg)
|
|
Pyrethrum Extract (100 mg)
|
|
Pyridostigmine Bromide (200 mg)
|
|
Pyridostigmine Related Compound A (50 mg) (Pyridin-3-yl dimethylcarbamate)
|
|
Pyridostigmine Related Compound B (10 mg) (3-Hydroxy-1-methylpyridin-1-ium bromide)
|
|
ピリドキシン塩酸塩 (Vitamin B6)
|
|
Pyrilamine Maleate (200 mg)
|
|
Pyrimethamine (200 mg)
|
|
Pyroglutamic Acid (30 mg) ((S)-5-Oxopyrrolidine-2-carboxylic acid)
|
|
パモ酸ピルビニウム
販売終了
|
|
p-Ranolazine (25 mg) (N-(2,6-Dimethylphenyl)-2-{4-[2-hydroxy-3-(4-methoxyphenoxy)propyl]piperazin-1-yl}acetamide)
|
|
Powdered Red Clover Extract (500 mg)
|
|
Powdered Rosemary Extract (1 g)
|
|
Powdered Rosemary Hydrophilic Extract (1 g)
|
|
Powdered St. John's Wort Extract (600 mg)
|
|
Phenylbutyrate Related Compound A (25 mg) (4-oxo-4-phenylbutanoic acid)
|
|
Phenylbutyrate Related Compound C (25 mg) (4-cyclohexylbutanoic acid) (COLD SHIPMENT REQUIRED)
|
|
Phenylbutyrate Related Compound B (100 mg) (3,4-dihydronaphthalen-1(2H)-one)
|
|
p-Toluenesulfonamide (200 mg)
|
|
p-Toluidine (50 mg) (COLD SHIPMENT REQUIRED)
|
|
Powdered Valerian Extract (1 g)
|
|